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Transglutaminases (TGases) are used in ﬁelds such as
food and pharmaceuticals. Unlike other TGases,
microbial transglutaminase (MTG) activity is Ca
21-inde-
pendent, broadening its application. Here, a three-dimen-
sional docking model of MTG binding to a peptide
substrate, CBZ-Gln-Gly, was simulated. The data reveal
CBZ-Gln-Gly to be stretched along the MTG active site
cleft with hydrophobic and/or aromatic residues interact-
ing directly with the substrate. Moreover, an oxyanion
binding site for TGase activity may be constructed from
the amide groups of Cys64 and/or Val65. Alanine muta-
genesis veriﬁed the simulated binding region and indi-
cated that large molecules can be widely recognized on
the MTG cleft.
Keywords: molecular dynamics/site-directed mutagenesis/
substrate docking/substrate speciﬁcity/transglutaminase
Introduction
Transglutaminases (TGase: protein-glutaminase
g-glutamyltransferase, EC 2.3.2.13) constitute a family of
enzymes that catalyze the replacement of the amide
ammonia at the g-position in glutamine residues with
another amine, usually an 1-amino group from a suitable
lysine residue (Lorand et al., 1962; Folk, 1970, 1980;
Dadabay et al., 1989). The formation of 1-(g-glutamyl)lysine
isopeptide bonds results in both intra- and intermolecular
cross-linking of proteins, leading to polymerization. The
incorporation of such covalent cross-links with microbial
transglutaminase (MTG) into food proteins, such as tofu,
boiled ﬁsh paste and sausage, improves their physical and
textural properties (Ikura et al., 1980; Motoki and Nio, 1983;
Kurth and Rogers, 1984). Recently, the covalent binding of
poly(ethyleneglycol) by TGase was reported as a promising
method for surface modiﬁcation to make protein drugs more
water soluble, non-aggregating, non-immunogenic and more
stable against proteolytic digestion (Fontana et al., 2008).
This unique application is possible due to the availability of
glutamine residues for attack by TGase in globular proteins
possessing regions characterized by enhanced chain
ﬂexibility, which are also favorable targets for proteases.
TGases are widely distributed in various organisms,
including vertebrates (Chung and Folk, 1972; Wong et al.,
1990; Weraarchakul-Boonmark et al., 1992; Grant et al.,
1994; Yasueda et al., 1995), invertebrates (Tokunaga
et al., 1993; Signh and Metha, 1994), mollusks (Klein et al.,
1992), plants (Margosiak et al., 1990) and microorganisms
(Kanaji et al., 1993). For example, human blood coagulation
factor XIII, which forms ﬁbrin clots in hemostasis and
wound healing by catalyzing the cross-linking between ﬁbrin
molecules, has been well characterized (Bruner-Lorand
et al., 1966; Gladner and Nossal, 1983; Ichinose et al., 1986;
Hornyak et al., 1989; Bishop et al., 1990; Hornyak and
Shafer, 1991), and its crystal structure has been determined
(Pedersen et al., 1994; Yee et al., 1994, 1995; Weiss et al.,
1998). The red sea bream liver transglutaminase (ﬁsh-derived
TGase, FTG) is a member of the tissue-type TGase family.
Reports indicate that the overall structure of FTG and human
factor XIII is similar (Noguchi et al., 2001). In contrast to
many other TGases, MTG activity is Ca
2þ-independent.
Moreover, its structure is very different from the others as
MTG adopts a disk-like shape with a deep cleft at the edge
of the disk. The residue essential for the catalytic activity,
Cys64, exists at the bottom of the cleft (Kashiwagi et al.,
2002).
A database for TGase substrate proteins, called TRANSDAB
(http://genomics.dote.hu/wiki/index.php/Main_Page), has pro-
duced useful information regarding sequence preference as this
database provides a list of previously identiﬁed substrates
(Facchiano et al., 2003). Additional sequences preferred by
MTG were discovered by analysis of reactive glutamine resi-
dues within substrates using phage display (Sugimura et al.,
2008). However, in spite of these studies on the structural prop-
erties and substrate speciﬁcity, little is known about substrate
recognition by TGases. One primary obstacle is the fact that the
substrate speciﬁcity is regulated by the protein primary
sequence and tertiary structure surrounding the glutamine resi-
dues, of which there may be several that could potentially act
as a substrate.
Ligand-docking experiments are a powerful approach for
investigating the binding mode. This is despite the exper-
imental challenges that arise in determining the complex
structure of an enzyme and its substrate due to weak inter-
actions and substrate turnover. In fact, a computational con-
formational analysis and docking study of potent factor XIII
inhibitors having a cyclopropenone ring have been
implemented previously (Iwata et al., 2000). Here, we
describe results from a docking study of MTG and a peptide
substrate, CBZ-Gln-Gly, including molecular dynamic simu-
lation and a proposed substrate recognition mechanism for
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conducted to verify the substrate binding region. Knowledge
of MTG binding with substrate will help further expand the
applications for MTG use.
Materials and methods
Docking study
The X-ray structure of MTG (Protein Data Bank entry 1IU4)
was used as an initial structure for the docking study.
A three-dimensional structure of the substrate, CBZ-Gln-Gly,
was constructed and minimized by Discovery Studio
(Accelrys Software Inc.). First, the structure of MTG was
prepared by removing all solvents and adding hydrogen
atoms. Then, the position of Cys64 S
g was changed, such
that its location was close enough for hydrogen bond for-
mation with Asp255 H
s2 as these residues are assumed to be
a catalytic diad (Kashiwagi et al., 2002). As a result, the x1
angle of the cysteine residue was rotated 688 from the X-ray
structure. His274 was also isomerized to make a wider
pocket for CBZ-Gln-Gly binding. After setting the charge
states of the Sg atom of Cys64 and Asp255 to be negative
and neutral (COOH), respectively, as shown previously
(Kashiwagi et al., 2002), they were minimized by a protein
preparation method using Prime (Schro ¨dinger, LLC) for the
docking study. The docking study and score calculations
were performed using Maestro (Schro ¨dinger, LLC). A grid
box for the molecular docking by Glide (Schro ¨dinger, LLC)
was set as a cube where each side was 17 A ˚, which was the
length of the stretched form of CBZ-Gln-Gly. The grid box
was deﬁned by the center of the two active site residues,
Cys64 and Asp255. CBZ-Gln-Gly was docked in the stan-
dard precision mode by Glide, up to 100 structures. These
docked structures were then classiﬁed into nine groups using
MOE (Chemical Computing Group Inc.); the structures in
each were within 4.5 A ˚ of the RMS deviations.
Molecular dynamics
All MD simulations were performed using the AMBER8
software package with the parm96 force ﬁeld. The complex
structures were surrounded with a 15 A ˚ layer of TIP3P water
molecules (Jorgensen et al., 1983). The electrostatic charge
was neutralized by adding counter ions using the LeaP
module of AMBER8. After minimization, heating and equili-
bration, the production MD phase was carried out at 300 K
for 10 ns with a time step of 1 fs using the constant volume
and temperature (NVT) ensemble and the PME algorithm.
All simulations were performed on an 8192 CPU core (4096
computing nodes) IBM BlueGene/L supercomputer at the
Computational Biology Research Center (CBRC).
Site-directed mutagenesis
Mutations encoding the amino acid substitutions, D3A, D4A,
R5A, R26A, Y62A, G63A, C64A, V65A, W69A, Y75A,
N239A, I240A, P241A, G250A, V252A, N253A, F254A,
D255A, Y256A, H274A, N276A, H277A, Y278A, S284A,
L285A, E300A, Y302A, D304A and F305A, were introduced
into the mtg gene by using the QuikChange mutagenesis kit
(Stratagene). The integrity of the mtg open reading frame
and the presence of the mutations were veriﬁed by DNA
sequencing. MTG and its variants were expressed and
puriﬁed as described previously (Yokoyama et al., 2000,2002).
TGase activity assay
TGase activity was measured by the calorimetric hydroxa-
mate procedure and an NMR-based screening method using
N-carbobenzoxy-L-glutaminyl-glycine and ovalbumin
(chicken egg albumin) as described previously (Folk and
Cole, 1966; Shimba et al., 2002a, 2002b).
Results and discussion
Binding simulation of CBZ-Gln-Gly to MTG
The docking program Glide was used initially to predict the
three-dimensional structure of MTG bound to CBZ-Gln-Gly.
A total of 100 docking structures were calculated and then
classiﬁed into nine groups based on the RMS deviations of
the ligand conformation (Fig. 1A and B). In Groups 1, 2, 3,
4 and 6, the distances between the Cys64 S
g atom in MTG
and the Gln C
d atom in CBZ-Gln-Gly were  4A ˚, indicating
that they were capable of an enzymatic reaction, since Cys64
S
g was assumed to be a nucleophilic atom. However, the
locations of Cys64 S
g in MTG and Gln C
d in CBZ-Gln-Gly
of the structures in Groups 5, 7, 8 and 9 were too far to be
active for the enzyme. Therefore, the docking structures in
Groups 1, 2, 3, 4 and 6 were selected as the ﬁrst candidates
for further investigation.
MD simulation of the complex
In Groups 1, 2, 3, 4 and 6, Cys64 S
g in MTG and Gln C
d in
CBZ-Gln-Gly were observed to be in the proper position for
the enzymatic reaction. However, an oxyanion binding site
was not found in any of the docking structures. To select a
proper model structure, MD simulation was performed on
the structures in Groups 1, 2, 3, 4 and 6. A centroid structure
for each group was calculated to be the initial conformation
by MOE. Figure 1C shows the distance proﬁles between
Cys64 S
g in MTG and Gln C
d in CBZ-Gln-Gly during the
10 ns MD simulation. Snapshots were taken every picose-
cond during the 10 ns production phase for a total of 10 000
snapshots. Cys64 S
g in MTG and Gln C
d in CBZ-Gln-Gly in
the docking structures of Group 3 remained in their proper
positions for more than 8 ns, whereas the substrate was
released quickly in structures from Groups 1, 2, 4 and
6. Consistency of the results were obtained in another inde-
pendent simulations with different initial velocities assigned
to the same starting structure for each docking group (data
not shown). We have also calculated the average binding free
energy from MD trajectories by MM-GBSA calculation in
AMBER program. The average binding free energy of
Groups 1, 2, 3, 4 and 6 were 25.42, 29.25, 216.48,
211.68 and 25.30 kcal/mol, respectively. Therefore, the
docking structures of Group 3 during the MD simulation
were selected as representing the proper structure.
Next, all trajectories were analyzed to ﬁnd the oxyanion
binding site. The g-carboxyl group of CBZ-Gln-Gly is
located within 4 A ˚ from both amide groups of Cys64 and
Val65 in the 692 trajectories of Group 3. However, oxyanion
binding sites were not observed in any trajectories calculated
from the initial structures from Groups 1, 2, 4 and 6. In
addition, a hydrogen bond between Cys64 S
g and Asp255
U.Tagami et al.
748O
d, which was assumed to form a catalytic diad with Cys64,
was formed in 7 out of the 692 trajectories assessed. All
seven conformations were oriented in the same direction on
the MTG molecule. As such, the docking structure with the
shortest distance between Cys64 S
g in MTG and Gln C
d in
CBZ-Gln-Gly was selected from the seven trajectories
(Fig. 2).
Alanine mutagenesis to verify the CBZ-Gln-Gly binding site
To identify the critical residues for substrate recognition, the
residues surrounding Cys64, which is essential for MTG
activity, were replaced with alanines, and the activities based
on the calorimetric hydroxamate procedure were measured
(Fig. 3, Table I). It should be noted that the substrate on the
calorimetric hydroxamate procedure was a small peptide-like
molecule, CBZ-Gln-Gly. These studies demonstrated no
activity for G63A, C64A, N253A, F254A, D255A, Y256A
and H277A, in which Cys64 was the catalytic residue and
Asp255 was assumed to be an electron donor. In addition,
TGase activities of the variants, Y62A, V65A, V252A,
N276A and Y278A, were reduced dramatically, indicating
that these residues are important for substrate recognition.
Residues contacting the substrate in the docking model
mostly overlapped with those within the substrate recognition
Fig. 1. (A) A total of 100 docking structures of MTG binding with CBZ-Gln-Gly were classiﬁed into nine groups based on the RMS deviations of the ligand
conformation. Glide scores are plotted in each group. (B) The distances between the Cys64 S
g atom in MTG and the Gln C
d atom in CBZ-Gln-Gly in each
group are shown. (C) Distance proﬁles between Cys64 S
g in MTG and Gln C
d in CBZ-Gln-Gly during the 10 ns MD calculation, which are plotted in red
(Group 1), green (Group 2), blue (Group 3), pink (Group 4) and orange (Group 6), are depicted. Snapshots were taken every picosecond during the 10 ns
production phase.
Fig. 2. (A) Docking structure of MTG binding with the substrate, CBZ-Gln-Gly. In CBZ-Gln-Gly, the CBZ, Gln and Gly moieties are shown in blue, cyan
and red, respectively. In MTG, Cys64, Val65 and Asp255 are depicted in green. (B) Schematic view of the interactions between CBZ-Gln-Gly and MTG.
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quency of interaction between MTG and CBZ-Gln-Gly
during the MD simulation (10 ns) was calculated using
LIGPLOT (Wallace et al., 1995) (Fig. 3). The catalytic
residue Cys64 displayed the greatest number of contacts in
the simulation. The results were sorted in descending order
of interaction frequency. Residues Tyr62, Gly63, Cys64,
Val65, Val252, Asn253, Phe254, Asp255, Tyr256, Asn276,
His277 and Tyr278, which interacted frequently with
CBZ-Gln-Gly during the MD simulation, were found to be
located within the region where alanine substitution led to
dramatic reduction of TGase activity. In contrast, most of the
residues which did not interact with CBZ-Gln-Gly also did
not inﬂuence TGase activity following alanine substitution.
Overall, these alanine mutagenesis studies were consistent
with the docking model of MTG bound with CBZ-Gln-Gly.
The catalytic site in the docking model consists of Cys64
in addition to an oxyanion binding site constructed from the
amide groups of Cys64 and/or Val65. Within this site, the
Val65 amide group was maintained in the proper orientation
by a hydrophobic interaction between the Val65 side chain
and Tyr62, Val67, Trp69, Tyr75, Pro76 and Tyr256.
CBZ-Gln-Gly was located in the cleft, which was con-
structed from loops formed by 239–253 and 276–288 within
MTG, and surrounded by hydrophobic and aromatic residues
such as Tyr62, Val65, Tyr75, Val252, Phe254, Tyr256,
Tyr278 and Leu285. These data suggest that substrate speci-
ﬁcity was deﬁned by hydrophobic and/or p–p interactions,
consistent with the peptide-sequence dependence of MTG
reactivity (Ohtsuka et al., 2000; Sugimura et al., 2008) in
which valine, leucine, isoleucine, phenylalanine, tyrosine or
tryptophan in close proximity to a glutamine residue are
preferable for substrate recognition.
In the model structure of the complex, CBZ-Gln-Gly was
stretched across the active site cleft of MTG. In particular,
Fig. 3. Frequency of interaction between MTG and CBZ-Gln-Gly during the MD simulation (dots) and relative activities of MTG variants in which residues
surrounded by Cys64 were replaced with alanine (bars). The activity of the variants was compared with the wild-type. Residue numbers are sorted in
descending order of interaction frequency.
Table I. TGase activities for the wild-type and variants determined by the
calorimetric hydroxamate procedure and the NMR-based screening method
Variants Calorimetric
hydroxamate
procedure (U/mg)
Relative
activity
(%)
NMR-based
screening
method
( 10
23 U/mg)
Relative
activity
(%)
Wild-type 26.3+0.2 100.0 44.8 100.0
D3A 25.5 97.0 ND ND
D4A 21.0 80.0 ND ND
R5A 24.4 92.6 ND ND
R26A 26.6+0.6 101.1 8.1 18.0
Y62A 8.5+1.3 32.2 ND ND
G63A 0.0 0.0 ND ND
C64A 0.0 0.0 0.2 0.4
V65A 2.6+0.0 9.8 4.6 10.2
W69A 41.8+4.3 158.9 ND ND
Y75A 31.6+0.3 120.2 2.4 5.3
N239A 17.9 68.2 ND ND
I240A 31.1+0.1 118.3 30.6 68.3
P241A 31.4+1.3 119.3 ND ND
G250A 20.3+1.4 77.4 ND ND
V252A 7.1+0.0 26.8 2.7 6.0
N253A 0.3+0.1 1.1 0.5 1.1
F254A 0.5+0.1 2.1 ND ND
D255A 0.4+0.4 1.6 0.1 0.2
Y256A 0.7+0.2 2.8 0.8 1.9
H274A 15.6+0.8 59.3 4.2 9.3
N276A 2.6+0.4 9.9 0.8 1.7
H277A 1.0+0.1 3.7 ND ND
Y278A 4.6+0.4 17.6 1.8 3.9
S284A 24.5+1.2 93.3 ND ND
L285A 28.6+0.2 108.7 16.5 36.8
E300A 29.9+0.2 113.7 24.5 54.7
Y302A 40.2+1.5 152.7 ND ND
D304A 16.1+0.1 61.2 18.4 41.1
F305A 16.2+0.2 61.6 8.4 18.6
Activities were assayed as described in the Materials and methods. RMS
deviations were calculated on the basis of two or three experiments.
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the rear vestibule of the cleft, whereas the glycine residue
was opposite in the front view of MTG, where the left side
wall of the cleft consists of an N-terminal loop (Asp1–
Ala10) and the loop 276–288, and the right side wall con-
sists of the loop 239–253. In addition, it has been speculated
that the ﬂexibility of the right side wall of the cleft might
decrease the steric hindrance between the enzyme and its
substrates due to the high B-factors from Arg242 to Gly250
in the crystal structure of MTG (Kashiwagi et al., 2002).
Protein substrates which are much larger than CBZ-Gln-Gly
may also be recognized by the outside of the active cleft,
which is aligned along CBZ-Gln-Gly in Figs 2A and 4A.
Substrate recognition of a larger molecule
To further investigate substrate recognition by MTG, TGase
reactivity to a protein substrate was estimated by NMR
(Table I). Instead of the CBZ-Gln-Gly substrate used in the
alanine mutagenesis study, ovalbumin was used in these
experiments (Shimba et al., 2002a, 2002b).
15N nuclei were
incorporated into the g-carboxyamide groups of the gluta-
mine residues in arbitrary proteins by the TGase reaction,
followed by NMR detection to evaluate the reactivity of the
enzymes on the protein substrate. In addition to the residues
found to be crucial for CBZ-Gln-Gly recognition, TGase
activities of the variants, Arg26, Tyr75, His274, Leu285,
Asp304 and Phe305, for the protein substrate were reduced
to less than half that of the wild-type. These residues were
located along the active site cleft (Fig. 4B), indicating that
the recognition site of a large molecule such as a protein
substrate is expansive on the surface of the cleft in MTG.
In the present study, we have shown that peptide/protein
substrates are recognized along the active site cleft of MTG,
and that the amide groups of Cys64 and/or Val65 are candi-
dates for the oxyanion binding site for TGase reactions. In
the model structure of the complex, numerous hydrophobic
and aromatic residues interacted directly with the substrate,
implicating analogous recognition mechanisms by many pro-
teases. A method to identify the speciﬁcity of proteases has
been reported previously, and the P2 position typically
shows a preference for hydrophobic amino acids (Harris
et al., 2000). For example, the P2 position of papain prefers
Val.Phe.Tyr.Nle and cruzein prefers Leu.Tyr.Phe
.Val. It may be possible that MTG and the proteases have
similar substrate preferences for hydrophobic amino acids in
the peptide/protein sequence. In addition, glutamine residues
Fig. 4. (A) Docking structure of MTG binding with CBZ-Gln-Gly, in which the CBZ Gln, and Gly moieties are shown in blue, cyan, and green, respectively.
Residues contacting CBZ-Gln-Gly are shown in orange. (B) Mapping of the residues onto the crystal structure, which was crucial for the TGase activity
demonstrated in the alanine mutagenesis study. TGase activity of the variants, C64A, V65A, V252A, N253A, D255A, Y256A, N276A and Y278A, was less
than half that of the wild-type for both substrates CBZ-Gln-Gly and ovalbumin (shown in cyan). In contrast, those of R26A, Y75A, H274A, L285A, D304A
and F305A were less than half only for ovalbumin (shown in yellow), and the activity of I240A and E300A was retained regardless of substrate (shown in
green).
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751attacked by MTG are located in regions characterized by
enhanced chain ﬂexibility, which are also favorable targets
for proteases. MTG, as well as the other TGases (Fontana
et al., 2008), has potential for use in surface modiﬁcation
applications to make proteins more stable against proteolytic
digestion.
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